A whole genome association study of mother-to-child transmission of HIV in Malawi

Genome Medicine

Volumn 2, Issue 3, 2010, Pages

  Joubert, Bonnie R ^a   Lange, Ethan M ^a,b,c   Franceschini, Nora ^a   Mwapasa, Victor ^d   North, Kari E ^a,c   Meshnick, Steven R ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALARIA; MALAWI; MALE; NEWBORN; PREGNANCY; PRIORITY JOURNAL; PROTEIN INTERACTION; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; VERTICAL TRANSMISSION; VIRUS LOAD;

EID: 78751691240     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm138     Document Type: Article

References (94)

1. Sub-Saharan Africa: Comprehensive Indicator Report. , http://hivinsite.ucsf.edu/global?page=cr09-00-00&post=20&cid=AOX
2. UNAIDS Report on the Global AIDS Epidemic: 2008 2008, Geneva: Joint United Nations programme on HIV/IADS (UNAIDS) and the World Health Organization, UNAIDS.
3. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958. 10.1126/science.272.5270.1955, 8658171.
4. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148. 10.1016/S0092-8674(00)81313-6, 8674119.
5. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666. 10.1038/381661a0, 8649511.
6. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158. 10.1016/S0092-8674(00)81314-8, 8674120.
7. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673. 10.1038/381667a0, 8649512.
8. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996, 35:3362-3367. 10.1021/bi952950g, 8639485.
9. Arenzana-Seisdedos F, Parmentier M. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. Semin Immunol 2006, 18:387-403. 10.1016/j.smim.2006.07.007, 16978874.
10. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'Connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005, 307:1434-1440. 10.1126/science.1101160, 15637236.
11. Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, Gray GE, Tiemessen CT. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. Aids 2007, 21:1753-1761. 10.1097/QAD.0b013e3282ba553a, 2386991, 17690574.
12. Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, Gray GE, Kuhn L, Tiemessen CT. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 2006, 87:2055-2065. 10.1099/vir.0.81709-0, 2365885, 16760409.
13. Shostakovich-Koretskaya L, Catano G, Chykarenko ZA, He W, Gornalusse G, Mummidi S, Sanchez R, Dolan MJ, Ahuja SS, Clark RA, Kulkarni H, Ahuja SK. Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. AIDS 2009, 23:679-688. 10.1097/QAD.0b013e3283270b3f, 19279442.
14. Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 2007, 8:1324-1336. 10.1038/ni1521, 17952079.
15. Kulkarni H, Agan BK, Marconi VC, O'Connell RJ, Camargo JF, He W, Delmar J, Phelps KR, Crawford G, Clark RA, Dolan MJ, Ahuja SK. CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals. PLoS One 2008, 3:e3165. 10.1371/journal.pone.0003165, 2522281, 18776933.
16. Shalekoff S, Meddows-Taylor S, Schramm DB, Donninger SL, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT. Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr 2008, 48:245-254. 10.1097/QAI.0b013e31816fdc77, 2562935, 18360285.
17. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273:1856-1862. 10.1126/science.273.5283.1856, 8791590.
18. Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, Murphy PM. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997, 3:23-36. 2230106, 9132277.
19. Contopoulos-Ioannidis DG, O'Brien TR, Goedert JJ, Rosenberg PS, Ioannidis JP. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis. J Acquir Immune Defic Syndr 2003, 32:70-76.
20. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, Mangano A, Sen L, Clark RA, Ahuja SS, Dolan MJ, Ahuja SK. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 2001, 98:5199-5204. 10.1073/pnas.091056898, 33187, 11320252.
21. Pedersen BR, Kamwendo D, Blood M, Mwapasa V, Molyneux M, North K, Rogerson SJ, Zimmerman P, Meshnick SR. CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLoS ONE 2007, 2:e838. 10.1371/journal.pone.0000838, 1950791, 17786209.
22. John GC, Bird T, Overbaugh J, Nduati R, Mbori-Ngacha D, Rostron T, Dong T, Kostrikis L, Richardson B, Rowland-Jones SL. CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. J Infect Dis 2001, 184:89-92. 10.1086/321006, 11398114.
23. Doranz BJ, Grovit-Ferbas K, Sharron MP, Mao SH, Goetz MB, Daar ES, Doms RW, O'Brien WA. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 1997, 186:1395-1400. 10.1084/jem.186.8.1395, 2199097, 9334380.
24. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-833. 10.1038/382829a0, 8752280.
25. Cohen OJ, Kinter A, Fauci AS. Host factors in the pathogenesis of HIV disease. Immunol Rev 1997, 159:31-48. 10.1111/j.1600-065X.1997.tb01005.x, 9416501.
26. De Clercq E, Schols D. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Antivir Chem Chemother 2001, 12(Suppl 1):19-31.
27. Brelot A, Heveker N, Montes M, Alizon M. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem 2000, 275:23736-23744. 10.1074/jbc.M000776200, 10825158.
28. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997, 16:6996-7007. 10.1093/emboj/16.23.6996, 1170303, 9384579.
29. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998, 279:389-393. 10.1126/science.279.5349.389, 9430590.
30. Dezzutti CS, Guenthner PC, Green TA, Cohen OJ, Spira TJ, Lal RB. Stromal-derived factor-1 chemokine gene variant is associated with the delay of HIV-1 disease progression in two longitudinal cohorts. Aids 2000, 14:894-896. 10.1097/00002030-200005050-00018, 10839599.
31. Mangano A, Kopka J, Batalla M, Bologna R, Sen L. Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection. J Acquir Immune Defic Syndr 2000, 23:52-57.
32. Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Blanche S, Delfraissy JF, Misrahi M. CCR2B-64I chemokine receptor allele and mother-to-child HIV-1 transmission or disease progression in children. French pediatric HIV infection study group. J Acquir Immune Defic Syndr 1999, 22:267-271.
33. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, Coleman N, Lee B. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002, 71:445-457.
34. Soilleux EJ, Morris LS, Lee B, Pohlmann S, Trowsdale J, Doms RW, Coleman N. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol 2001, 195:586-592. 10.1002/path.1026, 11745695.
35. Soilleux EJ, Coleman N. Transplacental transmission of HIV: a potential role for HIV binding lectins. Int J Biochem Cell Biol 2003, 35:283-287. 10.1016/S1357-2725(02)00132-2, 12531239.
36. Lee B, Leslie G, Soilleux E, O'Doherty U, Baik S, Levroney E, Flummerfelt K, Swiggard W, Coleman N, Malim M, Doms RW. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001, 75:12028-12038. 10.1128/JVI.75.24.12028-12038.2001, 116098, 11711593.
37. Koizumi Y, Kageyama S, Fujiyama Y, Miyashita M, Lwembe R, Ogino K, Shioda T, Ichimura H. RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retroviruses 2007, 23:713-719. 10.1089/aid.2006.0225, 17530998.
38. de Witte L, Bobardt M, Chatterji U, Degeest G, David G, Geijtenbeek TB, Gallay P. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci USA 2007, 104:19464-19469. 10.1073/pnas.0703747104, 2148312, 18040049.
39. Bobardt MD, Saphire AC, Hung HC, Yu X, Schueren B, Zhang Z, David G, Gallay PA. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 2003, 18:27-39. 10.1016/S1074-7613(02)00504-6, 12530973.
40. Hamon M, Mbemba E, Charnaux N, Slimani H, Brule S, Saffar L, Vassy R, Prost C, Lievre N, Starzec A, Gattegno L. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Glycobiology 2004, 14:311-323. 10.1093/glycob/cwh038, 15033938.
41. de Parseval A, Bobardt MD, Chatterji A, Chatterji U, Elder JH, David G, Zolla-Pazner S, Farzan M, Lee TH, Gallay PA. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem 2005, 280:39493-39504. 10.1074/jbc.M504233200, 16157597.
42. Argyris EG, Acheampong E, Nunnari G, Mukhtar M, Williams KJ, Pomerantz RJ. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. J Virol 2003, 77:12140-12151. 10.1128/JVI.77.22.12140-12151.2003, 254292, 14581551.
43. Bobardt MD, Chatterji U, Selvarajah S, Schueren B, David G, Kahn B, Gallay PA. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 2007, 81:395-405. 10.1128/JVI.01303-06, 1797244, 17050597.
44. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998, 4:350-353. 10.1038/nm0398-350, 9500612.
45. Martinson JJ, Hong L, Karanicolas R, Moore JP, Kostrikis LG. Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype. Aids 2000, 14:483-489. 10.1097/00002030-200003310-00003, 10780710.
46. Williamson C, Loubser SA, Brice B, Joubert G, Smit T, Thomas R, Visagie M, Cooper M, Ryst E. Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populations. Aids 2000, 14:449-451. 10.1097/00002030-200003100-00020, 10770549.
47. Modi WS, Goedert JJ, Strathdee S, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. Aids 2003, 17:2357-2365. 10.1097/00002030-200311070-00011, 14571188.
48. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Rowland-Jones SL. CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet 1998, 351:1632-1633. 10.1016/S0140-6736(05)77688-1, 9620723.
49. Easterbrook PJ, Rostron T, Ives N, Troop M, Gazzard BG, Rowland-Jones SL. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J Infect Dis 1999, 180:1096-1105. 10.1086/314997, 10479136.
50. Schinkel J, Langendam MW, Coutinho RA, Krol A, Brouwer M, Schuitemaker H. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users. J Infect Dis 1999, 179:825-831. 10.1086/314658, 10068577.
51. Magierowska M, Theodorou I, Debre P, Sanson F, Autran B, Riviere Y, Charron D, Costagliola D. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 1999, 93:936-941.
52. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947. 10.1126/science.1143767, 1991296, 17641165.
53. Welzel TM, Gao X, Pfeiffer RM, Martin MP, O'Brien SJ, Goedert JJ, Carrington M, O'Brien TR. HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples. Aids 2007, 21:225-229. 10.1097/QAD.0b013e3280123840, 17197814.
54. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001, 344:1668-1675. 10.1056/NEJM200105313442203, 11386265.
55. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005, 11:1290-1292. 10.1038/nm1333, 16288280.
56. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999, 283:1748-1752. 10.1126/science.283.5408.1748, 10073943.
57. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002, 31:429-434.
58. Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, Kirk GD, O'Brien SJ, Trowsdale J, Carrington M. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2006, 2:e79. 10.1371/journal.ppat.0020079, 1550271,1550271, 16933987.
59. Winchester R, Pitt J, Charurat M, Magder LS, Goring HH, Landay A, Read JS, Shearer W, Handelsman E, Luzuriaga K, Hillyer GV, Blattner W. Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. J Acquir Immune Defic Syndr 2004, 36:659-670. 10.1097/00126334-200406010-00002, 15167284.
60. Aikhionbare FO, Kumaresan K, Shamsa F, Bond VC. HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther 2006, 3:28. 10.1186/1742-6405-3-28, 1634865, 17059603.
61. Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006, 68:193-209. 10.1111/j.1399-0039.2006.00649.x, 16948640.
62. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003, 40:73-84. 10.1016/S0161-5890(03)00104-4, 12914814.
63. Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002, 12:335-352. 10.1046/j.1365-3148.2002.00408.x, 12473150.
64. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998, 199:327-339.
65. Boniotto M, Crovella S, Pirulli D, Scarlatti G, Spano A, Vatta L, Zezlina S, Tovo PA, Palomba E, Amoroso A. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 2000, 1:346-348. 10.1038/sj.gene.6363685, 11196698.
66. Simon JH, Gaddis NC, Fouchier RA, Malim MH. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 1998, 4:1397-1400. 10.1038/3987, 9846577.
67. Singh KK, Spector SA. Host genetic determinants of HIV infection and disease progression in children. Pediatr Res 2009, 65:55R-63R. 10.1203/PDR.0b013e31819dca03, 19190524.
68. Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, Molyneux ME, Kamwendo DD, Tadesse E, Chaluluka E, Meshnick SR. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. Aids 2006, 20:1869-1877. 10.1097/01.aids.0000244206.41500.27, 16954728.
69. Mwapasa V, Rogerson SJ, Molyneux ME, Abrams ET, Kamwendo DD, Lema VM, Tadesse E, Chaluluka E, Wilson PE, Meshnick SR. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. Aids 2004, 18:1051-1059. 10.1097/00002030-200404300-00014, 15096809.
70. StataCorp Stata Statistical Software: Release 10 2007, College Station, TX: StataCorp LP, StataCorp.
71. Rothman K, Greenland S. Modern Epidemiology 1998, Philapdelphia: Lippincott-Raven Publishers, Inc.
72. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, 2006. , http://hydra.usc.edu/gxe/
73. Thorisson GA, Smith AV, Krishnan L, Stein LD. The International HapMap Project Web site. Genome Res 2005, 15:1592-1593. 10.1101/gr.4413105, 1310647, 16251469.
74. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
75. Ge D, Zhang K, Need AC, Martin O, Fellay J, Telenti A, Goldstein D. WGAViewer: a software for genomic annotation of whole genome association studies. Genome Res 2008, 18:640-643. 10.1101/gr.071571.107, 2279251, 18256235.
76. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet 2006, 2:e190. 10.1371/journal.pgen.0020190, 1713260,1713260, 17194218.
77. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909. 10.1038/ng1847, 16862161.
78. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99:13-22. 10.1016/S0092-8674(00)80058-6, 10520990.
79. Liu J, Thorp SC. Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 2002, 22:1-25. 10.1002/med.1026, 11746174.
80. Crublet E, Andrieu JP, Vives RR, Lortat-Jacob H. The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. J Biol Chem 2008, 283:15193-15200. 10.1074/jbc.M800066200, 18378683.
81. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001, 276:3254-3261. 10.1074/jbc.M006701200, 11024024.
82. Vidricaire G, Gauthier S, Tremblay MJ. HIV-1 infection of trophoblasts is independent of gp120/CD4 Interactions but relies on heparan sulfate proteoglycans. J Infect Dis 2007, 195:1461-1471. 10.1086/515576, 17436226.
83. Vives RR, Imberty A, Sattentau QJ, Lortat-Jacob H. Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. J Biol Chem 2005, 280:21353-21357. 10.1074/jbc.M500911200, 15797855.
84. Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 2001, 75:9187-9200. 10.1128/JVI.75.19.9187-9200.2001, 114487, 11533182.
85. Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. Biochim Biophys Acta 2003, 1617:80-88. 10.1016/j.bbamem.2003.09.006, 14637022.
86. Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. Glycobiology 2003, 13:623-634. 10.1093/glycob/cwg083, 12773479.
87. Tkachenko E, Rhodes JM, Simons M. Syndecans: new kids on the signaling block. Circ Res 2005, 96:488-500. 10.1161/01.RES.0000159708.71142.c8, 15774861.
88. Sayers EW, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, DiCuccio M, Edgar R, Federhen S, Feolo M, Geer LY, Helmberg W, Kapustin Y, Landsman D, Lipman DJ, Madden TL, Maglott DR, Miller V, Mizrachi I, Ostell J, Pruitt KD, Schuler GD, Sequeira E, Sherry ST, Shumway M, Sirotkin K, Souvorov A, Starchenko G, Tatusova TA, Wagner L, Yaschenko E, Ye J. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2009, 37:D5-D15. 10.1093/nar/gkn741, 2686545, 18940862.
89. Rozier L, El-Achkar E, Apiou F, Debatisse M. Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene 2004, 23:6872-6880. 10.1038/sj.onc.1207809, 15286716.
90. Smith DI, Zhu Y, McAvoy S, Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 2006, 232:48-57. 10.1016/j.canlet.2005.06.049, 16221525.
91. Nomura N, Zu YL, Maekawa T, Tabata S, Akiyama T, Ishii S. Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. J Biol Chem 1993, 268:4259-4266.
92. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007, 104:1655-1660. 10.1073/pnas.0610291104, 1776164,1776164, 17234809.
93. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795-802.
94. Online Mendelian Inheritance in Man (OMIM). , http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim